Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Fecal Microbiota Transplantation (FMT) + MoviPrep + Omeprazole + Vancomycin & Autism Spectrum Disorder, the non-randomized, small open-label clinical phase I/II treatment trial NCT02504554 - Fecal Microbiota Transplantation (FMT) + MoviPrep + Omeprazole + Vancomycin & Autism Spectrum Disorder revealed that the exploratory, extended-duration treatment protocol seems to offer a promising method for altering the gut microbiome and virome, which in turn may improve gastrointestinal and behavioral symptoms associated with ASD. Notably, the improvements in gastrointestinal symptoms, ASD symptoms, and the microbiome were sustained for at least eight weeks following the conclusion of the treatment, indicating a potential …